138 related articles for article (PubMed ID: 38557857)
21. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
[TBL] [Abstract][Full Text] [Related]
22. Entecavir Combined With Short-term Hepatitis B Immunoglobulin in Preventing Hepatitis B Virus Recurrence in Liver Transplant Recipients.
Zheng H; Zhu Z; Wang N; Qin J; Guo Y; Xu Z; Li X; Qi C; Yuan X; Wu W; Wang J; Liu L; Nashan B
Transplant Proc; 2023 Mar; 55(2):408-412. PubMed ID: 36907782
[TBL] [Abstract][Full Text] [Related]
23. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
Cholongitas E; Goulis J; Akriviadis E; Papatheodoridis GV
Liver Transpl; 2011 Oct; 17(10):1176-90. PubMed ID: 21656655
[TBL] [Abstract][Full Text] [Related]
25. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS
Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
McGonigal KH; Bajjoka IE; Abouljoud MS
Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810
[TBL] [Abstract][Full Text] [Related]
27. Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective.
Edwards D; Lin J; Toman L; Gurakar M; Pustavoitau A; Kohli R; Wesson R; Ottmann SE; Dao D; Gurakar A; Kim A
Hepatol Forum; 2023 Jan; 4(1):3-6. PubMed ID: 36843892
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta-analysis.
Lai Q; Mennini G; Giovanardi F; Rossi M; Giannini EG
Eur J Clin Invest; 2021 Aug; 51(8):e13575. PubMed ID: 33866547
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin.
Ganbold A; Bayarsaikhan S; Chimedtseren M; Noronrenchin O; Ochirkhuree B
Clin Transplant Res; 2024 Mar; 38(1):46-51. PubMed ID: 38448049
[TBL] [Abstract][Full Text] [Related]
30. Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.
Varghese J; Reddy MS; Cherian T; Vijaya S; Jayanthi V; Rela M
Indian J Gastroenterol; 2014 May; 33(3):226-30. PubMed ID: 24760685
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic managements of hepatitis B viral infection in liver transplantation.
Onoe T; Tahara H; Tanaka Y; Ohdan H
World J Gastroenterol; 2016 Jan; 22(1):165-75. PubMed ID: 26755868
[TBL] [Abstract][Full Text] [Related]
32. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK; Choi JY
J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
[TBL] [Abstract][Full Text] [Related]
33. Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety.
Darweesh SK; Gad AA; Akroof K; ElLatif ZA
Eur J Gastroenterol Hepatol; 2019 May; 31(5):607-612. PubMed ID: 30724767
[TBL] [Abstract][Full Text] [Related]
34. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
35. The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV-related diseases in the era of potent nucleos(t)ide analogues: A meta-analysis.
Li MS; Hou ZH; Yao GZ; Tan M
J Dig Dis; 2021 Feb; 22(2):91-101. PubMed ID: 33128339
[TBL] [Abstract][Full Text] [Related]
36. Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Khemichian S; Hsieh MJ; Zhang SR; Limurti J; Kim J; Fong TL
Dig Dis Sci; 2015 Sep; 60(9):2807-12. PubMed ID: 25939541
[TBL] [Abstract][Full Text] [Related]
37. Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation.
Hu TH; Chen CL; Lin CC; Wang CC; Chiu KW; Yong CC; Liu YW; Eng HL
Transplantation; 2014 Apr; 97 Suppl 8():S53-9. PubMed ID: 24849836
[TBL] [Abstract][Full Text] [Related]
38. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
Radhakrishnan K; Chi A; Quan DJ; Roberts JP; Terrault NA
Transplantation; 2017 Sep; 101(9):2079-2082. PubMed ID: 28880197
[TBL] [Abstract][Full Text] [Related]
39. The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.
Tanaka T; Benmousa A; Marquez M; Therapondos G; Renner EL; Lilly LB
Clin Transplant; 2012; 26(5):E561-9. PubMed ID: 23061767
[TBL] [Abstract][Full Text] [Related]
40. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.
Roche B; Roque-Afonso AM; Nevens F; Samuel D
Transplantation; 2015 Jul; 99(7):1321-34. PubMed ID: 26038873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]